Vertex Information Rights. 11.6.1. If Vertex determines in good faith that CRISPR (or any CRISPR Entity(ies)) is an entity that is subject to financial consolidation with Vertex for the purposes of its quarterly and annual financial statements (or otherwise requires such information in order to comply with GAAP), CRISPR will make available to Vertex:
Appears in 2 contracts
Samples: Option and License Agreement, Collaboration, Option and License Agreement (Vertex Pharmaceuticals Inc / Ma)
Vertex Information Rights. 11.6.1. 12.6.1 If Vertex determines in good faith that CRISPR (or any CRISPR Entity(ies)) is an entity that is subject to financial consolidation with Vertex for the purposes of its quarterly and annual financial statements (or otherwise requires such information in order to comply with GAAP), CRISPR will make available to Vertex:
Appears in 2 contracts
Samples: Collaboration, Option and License Agreement (CRISPR Therapeutics AG), Collaboration, Option and License Agreement (CRISPR Therapeutics AG)
